We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

The FDA's green light for GOMEKLI is a significant achievement for SpringWorks, especially as it comes with a rare pediatric disease priority review voucher, which could be valued at around $100 ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.&nb ...

A 66-year-old New Hampshire man received the kidney as part of a small pilot study at Mass General Brigham. United Therapeutics, another developer of gene-edited pig organs, just won FDA approval for ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...